Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
The stock's rise snapped a four-day losing streak.
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western study Fast Track Designation granted by FDA for CRB-701 to treat metastatic cervical cancerCRB 913 SAD/MAD obesity ...
Corbus Pharmaceuticals (NASDAQ:CRBP) Receives Outperform Rating from Wedbush
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at ...
Corbus Pharmaceuticals: Q4 Earnings Snapshot
NORWOOD, Mass. (AP) — NORWOOD, Mass. (AP) — Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $9.5 million in its fourth quarter. The Norwood, Massachusetts-based company said ...
HC Wainwright Has Bullish Forecast for CRBP Q1 Earnings
Equities research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for shares of Corbus Pharmaceuticals in a research note issued to investors on Wednesday, March ...
Investing7d
Corbus Pharmaceuticals appoints new COO
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a biopharmaceutical company with a market capitalization of $77 million, announced on Monday the appointment of Ian Hodgson as the new Chief ...